Split History
ETFs Holding ALIM »    ALIM Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Alimera Sciences is a pharmaceutical company that is engaged in the commercialization and development of prescription ophthalmic pharmaceuticals. Co.'s commercial product is ILUVIEN®, an intravitreal implant that treats patients by delivering a continuous microdose of the non-proprietary corticosteroid fluocinolone acetonide in the eye. ILUVIEN was initially developed to treat diabetic macular edema, a disease of the retina that affects individuals with diabetes and can lead to vision loss and blindness. Co. commercially markets ILUVIEN in the United States, Germany, the United Kingdom, Portugal, Austria and Ireland. Co. has three segments: the United States, International and Other. According to our ALIM split history records, Alimera Sciences has had 1 split.
ALIM split history picture
Alimera Sciences (ALIM) has 1 split in our ALIM split history database. The split for ALIM took place on November 15, 2019. This was a 1 for 15 reverse split, meaning for each 15 shares of ALIM owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.

When a company such as Alimera Sciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ALIM split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Alimera Sciences shares, starting with a $10,000 purchase of ALIM, presented on a split-history-adjusted basis factoring in the complete ALIM split history. ALIM split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/27/2010
End date: 05/26/2020
Start price/share: $121.50
End price/share: $5.39
Dividends collected/share: $0.00
Total return: -95.56%
Average Annual Total Return: -26.76%
Starting investment: $10,000.00
Ending investment: $443.35
Years: 10.01
Date Ratio
11/15/20191 for 15
ALIM is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ALKS Split History
ALPN Split History
ALQA Split History
ALR Split History
ALT Split History
ALXA Split History
ALXN Split History
AMDA Split History
AMED Split History
AMGN Split History

Also explore: ALIM shares outstanding history

Laredo Petroleum, Inc. (LPI)
Global Eagle Entertainment Inc. (ENT)
ToughBuilt Industries, Inc. (TBLT)
Cyclacel Pharmaceuticals, Inc. (CYCC)
Chesapeake Energy Corporation (CHK)
Direxion Daily Gold Miners Index Bull 3X Shares (NUGT)
Direxion Zacks MLP High Income Index Shares (ZMLP)
Direxion Daily Retail Bull 3X Shares (RETL)
Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 3X Shares (UBOT)
Direxion Daily Junior Gold Miners Index Bull 3X Shares (JNUG)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ALIM Insider Buying

ALIM Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.